Schedule 13D ownership disclosure

Mirati Therapeutics Inc

Security class unavailable · CUSIP: 60468T105

Event date: 2016-03-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-092315
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Apr 01, 2016
Reporting period
Mar 30, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub